Prevexxion RN
Marek's disease vaccine (live recombinant)
Table of contents
Overview
Prevexxion RN is a veterinary vaccine used in one-day-old chicks to prevent death and disease and to reduce lesions caused by Marek’s disease (MD) virus (including very virulent MD virus).
MD is a herpesvirus infection of chickens which can cause paralysis of the wings and legs and tumours in various organs. Chickens become infected at an early age via inhalation of dander (flakes of skin) containing the virus which can remain infectious for several months after being shed from the body. Birds infected with MD virus can be carriers and shedders of the virus for life.
Prevexxion RN contains cells with a live recombinant strain of MD virus, serotype 1 called RN1250 that has been modified to increase its effectiveness and safety.
Authorisation details
Product details | |
---|---|
Name |
Prevexxion RN
|
Agency product number |
EMEA/V/C/005058
|
Active substance |
Live recombinant Marek’s disease (MD) virus, serotype 1, strain RN1250
|
International non-proprietary name (INN) or common name |
Marek's disease vaccine (live recombinant)
|
Species |
Chicken
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QI01AD03
|
Publication details | |
---|---|
Marketing-authorisation holder |
Boehringer Ingelheim Vetmedica GmbH
|
Revision |
3
|
Date of issue of marketing authorisation valid throughout the European Union |
20/07/2020
|
Contact address |
55216 Ingelheim am Rhein |
Product information
20/12/2021 Prevexxion RN - EMEA/V/C/005058 - IG/1450
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
Immunologicals for aves
Therapeutic indication
For active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by Marek’s disease (MD) virus (including very virulent MD virus).